4-[2-[[(2S)-butan-2-yl]amino]-8-(2-chloro-6-fluoroanilino)purin-9-yl]cyclohexane-1-carboxamide
C22H27ClFN7O — CID 121261032
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[2-[[(2S)-butan-2-yl]amino]-8-(2-chloro-6-fluoroanilino)purin-9-yl]cyclohexane-1-carboxamide
4-[2-[[(2S)-butan-2-yl]amino]-8-(2-chloro-6-fluoroanilino)purin-9-yl]cyclohexane-1-carboxamide (PubChem CID 121261032) has the molecular formula C22H27ClFN7O and a molecular weight of 459.96 g/mol. Its IUPAC name is 4-[2-[[(2S)-butan-2-yl]amino]-8-(2-chloro-6-fluoroanilino)purin-9-yl]cyclohexane-1-carboxamide.
Molecular Properties
| Compound Name | 4-[2-[[(2S)-butan-2-yl]amino]-8-(2-chloro-6-fluoroanilino)purin-9-yl]cyclohexane-1-carboxamide |
|---|---|
| PubChem CID | 121261032 |
| Molecular Formula | C22H27ClFN7O |
| Molecular Weight | 459.96 g/mol |
| Exact Mass | 459.19 |
| IUPAC Name | 4-[2-[[(2S)-butan-2-yl]amino]-8-(2-chloro-6-fluoroanilino)purin-9-yl]cyclohexane-1-carboxamide |
| SMILES | CC[C@H](C)Nc1ncc2nc(Nc3c(F)cccc3Cl)n(C3CCC(C(N)=O)CC3)c2n1 |
| InChI | InChI=1S/C22H27ClFN7O/c1-3-12(2)27-21-26-11-17-20(30-21)31(14-9-7-13(8-10-14)19(25)32)22(28-17)29-18-15(23)5-4-6-16(18)24/h4-6,11-14H,3,7-10H2,1-2H3,(H2,25,32)(H,28,29)(H,26,27,30)/t12-,13?,14?/m0/s1 |
| InChIKey | YFINKUUWTAPGRU-HSBZDZAISA-N |
| XLogP | 4.79 |
| TPSA | 110.75 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 459.96 |
| LogP ≤ 5 | 4.79 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121261032 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.